Follow us on

Saturday, May 18, 2013 | 7:20 p.m.

Men's Health

5 items
FILE - In this July 7, 2006 file photo an unidentified initiate, with his face caked in white lime clay, eats rice from his blanket during his rite of transformation from a boy to manhood near Port St. John's, South Africa. South African police say 23 youths have died over a period of nine days at initiation ceremonies that include circumcisions and survival tests. (AP Photo/Obed Zilwa-file)

23 dead in initiation rites in South Africa

Twenty-three youths have died in the past nine days at initiation ceremonies that include circumcisions and survival tests, South African police said Friday. Police have opened 22 murder cases in the deaths in the northeastern province of Mpumalanga, according to spokesman Lt. Col. Leonard Hlathi. He said an inquest is ...

US approves radiation-based prostate cancer drug

The U.S. Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones. The FDA said Wednesday it approved the drug, Xofigo from Bayer Pharmaceuticals, for men whose cancer has grown into bone tumors even after receiving ...

FDA approves radiation-based prostate cancer drug

The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones. The FDA said Wednesday it approved the drug, Xofigo from Bayer Pharmaceuticals, for men whose cancer has grown into bone tumors even after receiving medication ...

News Summary: Gene test may help cancer treatment

BREAKTHROUGH: A new genetic test to gauge the aggressiveness of prostate cancer may help men decide whether they need to treat their cancer right away or can safely monitor it. PROVIDING ANSWERS: Doctors say such tests can prevent overtreatment, a major problem in cancer care. Prostate tumors usually grow so ...

Prostate cancer patient Dean Smith, left, a retired marketing executive, meets with Dr. Peter Carroll, right, at the UCSF Medical Center in San Francisco on Thursday, May 2, 2013. Carroll, chairman of urology at the University of California, San Francisco says a study he led on a new prostate cancer test - the Oncotype DX Genomic Prostate Score - suggested it could triple the number of men known to be at such low risk for aggressive disease that monitoring is a clearly safe option. Conversely, the test also suggested that some tumors were more aggressive than doctors had believed. (AP Photo/Eric Risberg)

Gene test may help guide prostate cancer treatment

A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. The new test, which goes on sale Wednesday, joins another one that recently came on ...

5 items
 
Featured Articles
Ads By Google